Health- and vision-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery: Submacular surgery trials report no. 5

Archives of Ophthalmology

Volumn 123, Issue 1, 2005, Pages 78-88

  Hawkins, Barbara S ^a  

^a SST Coordinating Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; GENDER; HUMAN; IDIOPATHIC DISEASE; INTERVIEW; LINEAR REGRESSION ANALYSIS; MALE; OCULAR HISTOPLASMOSIS; OUTCOMES RESEARCH; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; READING; RETINA MACULA DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VISION; VISION TEST; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; CHOROIDAL NEOVASCULARIZATION; EYE INFECTIONS, FUNGAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; HEALTH STATUS INDICATORS; HISTOPLASMOSIS; HUMANS; MALE; MIDDLE AGED; QUALITY ASSURANCE, HEALTH CARE; QUALITY OF LIFE; QUESTIONNAIRES; VISION; VISUAL ACUITY;

EID: 12144266589     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.123.1.78     Document Type: Article

References (40)

1. Woods AC, Wahlen HE. The probable role of benign histoplasmosis in the etiology of granulomatous uveitis. Trans Am Ophthalmol Soc. 1959;57:318-343.
2. Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis. 1969;99(suppl):1-132.
3. Van Metre TE, Maumenee AE. Specific ocular uveal lesions in patients with evidence of histoplasmosis. Arch Ophthalmol. 1964;71:314-324.
4. Makley TA, Long SW, Suie T, Stephan JD. Presumed histoplasmic chorioretinitis with special emphasis on the present modes of therapy. Trans Am Acad Ophthalmol Otolaryngol. May-June 1965:443-457.
5. Schlaegel TF, Weber JC. Follow-up study of presumed histoplasmic choroiditis. Am J Ophthalmol. 1971;71:1192-1195.
6. Gass JD, Wilkinson CP. Follow-up study of presumed ocular histoplasmosis. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:672-694.
7. Feman SS, Podgorski SF, Penn MK. Blindness from presumed ocular histoplasmosis in Tennessee. Ophthalmology. 1982;89:1295-1298.
8. Macular Photocoagulation Study Group. Argon laser photocoagulation for ocular histoplasmosis: results of a randomized clinical trial. Arch Ophthalmol. 1983; 101:1347-1357.
9. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis: results of a randomized clinical trial. Arch Ophthalmol. 1987;105:1499-1507.
10. Macular Photocoagulation Study Group. Argon laser photocoagulation for idiopathic neovascularization: results of a randomized clinical trial. Arch Ophthalmol. 1983;101:1358-1361.
11. Ware JE. Evaluating measures of general health concepts for use in clinical trials. In: Furberg C, Schuttinga JA, eds. Quality of Life Assessment: Practice, Problems, and Promise: Proceedings of a Workshop, October 15-17, 1990. Washington, DC: US Dept of Health and Human Services; 1993:51-63. NIH publication 93-3503.
12. Patrick DL. Reactions and recommendations: quality of life in NIH-sponsored studies. In: Furberg C, Schuttinga JA, eds. Quality of Life Assessment: Practice, Problems, and Promise: Proceedings of a Workshop, October 15-17, 1990. Washington, DC: US Dept of Health and Human Services; 1993:81-88. NIH publication 93-3503.
13. Drummond MF, Ferris FL. Major themes and conclusions: a strategy for measurement of quality of life in National Eye Institute trials. In: Drummond MF, ed. Measuring the Quality of Life of People With Visual Impairment: Proceedings of a Workshop. Washington, DC: US Dept of Health and Human Services; 1990: 65-66. NIH publication 90-3098.
14. McDowell I. General health measurement and quality of life in visual impairment. In: Drummond MF, ed. Measuring the Quality of Life of People With Visual Impairment: Proceedings of a Workshop. Washington, DC: US Dept of Health and Human Services; 1990:29-33. NIH publication 90-3098.
15. Submacular Surgery Trials Research Group. Submacular Surgery Trials (SST) Manual of Procedures. Springfield, Va: National Technical Information Service; 1998. NTIS accession No. PB98-166648.
16. Submacular Surgery Trials Research Group. Submacular Surgery Trials (SST) Forms Book. Springfield, Va: National Technical Information Service; 1998. NTIS accession No. PB98-159445.
17. Dong LM, Hawkins BS, Marsh MJ. Consistency between visual acuity scores obtained at different test distances: theory vs observation in multiple studies. Arch Ophthalmol. 2002;120:1523-1533.
18. Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vision Sci. 1988;2:187-199.
19. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991;109:1220-1231.
20. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD; National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050-1058.
21. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD; NEI-VFQ Field Test Investigators. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol. 1998;116:1496-1504.
22. Ware JE, Snow KK, Kosinski M, Gaskel B. SF-36 Health Survey Manual and Interpretation Guide. Boston, Mass: Health Institute, New England Medical Center; 1993.
23. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361-370.
24. Submacular Surgery Trials Research Group. Patients' perceptions of the value of current vision: assessment of preference values among patients with subfoveal choroidal neovascularization - the Submacular Surgery Trials Vision Preference Value Scale: SST report No. 6. Arch Ophthalmol. 2004;122:1856-1867.
25. VFQ-25 Rand Health homepage. Available at: http://www.rand.org/health/ surveys /vfq25/. Accessed September 24, 2004.
26. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, Mass: Health Institute, New England Medical Center; 1994.
27. Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SJ. The psychological impact of macular degeneration. Arch Ophthalmol. 1998;116:514-520.
28. Submacular Surgery Trials Research Group. Effect of order of administration of QOL interview instruments on responses: SST report No. 3. QOL. Res. In press.
29. Armitage P, Berry G. Statistical Methods in Medical Research. 2nd ed. Boston, Mass: Blackwell Scientific Publications Inc; 1987:372-374.
30. Tukey JW. Exploratory Data Analysis. Reading, Mass: Addison-Wesley Publishing Co; 1977:34-41.
31. Snedecor GW, Cochran WG. Shortcut and nonparametric methods. In: Statistical Methods. 7th ed. Ames: Iowa State University Press; 1980:144-145.
32. Snedecor GW, Cochran WG. Correlation. In: Statistical Methods. 7th ed. Ames: Iowa State University Press; 1980:175-193.
33. Draper NR, Smith H. Applied Regression Analysis. New York, NY: John Wiley & Sons Inc; 1966:44-142.
34. Miskala PH, Bressler NM, Meinert CL. Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. Arch Ophthalmol. 2004;122:758-766.
35. Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2001;108:1893-1901.
36. Parrish RK, Gedde SJ, Scott IU, et al. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997;115:1447-1455.
37. Cole SR, Beck RW, Moke PS, Gal RL, Long DT; Optic Neuritis Study Group. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Invest Ophthalmol Vis Sci. 2000;41:1017-1021.
38. Schiffman RM, Jacobsen G, Whitcup SM. Visual functioning and general health status in patients with uveitis. Arch Ophthalmol. 2001;119:841-849.
39. Clemons TE, Chew EY, Bressler SB, McBee W; AREDS Research Group. National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS report No. 10. Arch Ophthalmol. 2003;121:211-217.
40. Macular Photocoagulation Study Group. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Arch Ophthalmol. 1996;114:677-688.